EAACI Congress 2024

31 May - 03 June 2024 Valencia, Spain

JMA Poster session 01 - Allergen immunotherapy/Biologicals

Friday 31 May, 16:45 PM - 18:15 PM Valencia, Spain
Poster Zone JMA Poster Session
5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
A New Immunotoxin Design against Allergy Based on the IL33 Cytokine and the Ribotoxin α-Sarcin
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
Dupilumab dose reduction in controlled severe atopic dermatitis and predictive factors
Effect of allergen specific immunotherapy on PFS symptoms
Fast dissociation of the IgE/FcεRI complex by engaging the Cε2 domain with allosteric, bi-specific IgE inhibitors
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results
MRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens
Mesoporous silica nanoparticles for allergy diagnosis and therapy
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
Polyclonal desensitization impairs mast cell responses in an allergen specific manner without compromising IgE signaling ability
Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted olive-grasses allergen extract
Regulation of IgE-dependent histamine production by human neutrophils
The association between baseline IgE levels and response to standard-dose omalizumab in uncontrolled chronic urticaria patients
The cross-protective activity of allergen immunotherapy-induced blocking antibodies accords with the structural identity of allergens
The effect of therapies targeting Type 2 inflammation on Neutrophil Extracellular Traps (NETs) and Extracellular Eosinophilic Traps (EETs) in severe CRSwNP
The potential role of IgE in Crohn’s disease by impairing the generation of FOXP3+ regulatory T cells by plasmacytoid dendritic cells